An open-label long-term evaluation of a novel intravaginal device in female patients experiencing sexual and bladder function issues.

To determine the long-term clinical efficacy of the vSculpt therapy on treating the pelvic floor area and vaginal tissue for females who experience bladder and sexual dysfunction.

Inclusion Criteria:

• All study participants are required to be biological females (genotype XX) to participate
• Female participants will be of adult age, over 18
• Female participants with self-reported concerns with bladder and sexual function
• Female participants who have reliable and consistent computer and internet access on a daily basis

Exclusion Criteria:

• Female participants shall not have an active sexually transmitted disease and/or infection
• Female participants who are actively undergoing chemotherapy or radiation
• Female participants who are currently taking any cancer-related or photosensitivity drugs
• Female participants who are pregnant, who may think they are pregnant, and/or actively trying to get pregnant during the clinical study